Compass Pathways (NASDAQ:CMPS) could secure US regulatory approval for its experimental depression treatment COMP360 as early as December or...
Compass Pathways (NASDAQ:CMPS) could secure US regulatory approval for its experimental...
MariMed CEO Jon Levine joined Steve Darling from Proactive to discuss the company's strongest financial quarter to date, highlighting record revenue growth, improving margins and continued expansion of its branded cannabis portfolio.Levine said the company's latest quarter marked a...